Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
24.39 USD | +0.04% | -22.48% | +25.94% |
09-05 | Top Premarket Decliners | MT |
09-04 | Credo Technology Group Holding Ltd Provides Earnings Guidance for the Second Quarter of 2025 | CI |
Fiscal Period: April | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Revenues | 53.84M | 58.7M | 106M | 184M | 193M |
Total Revenues | 53.84M | 58.7M | 106M | 184M | 193M |
Cost of Goods Sold, Total | 7.73M | 20.42M | 40.71M | 78M | 73.54M |
Gross Profit | 46.11M | 38.28M | 65.77M | 106M | 119M |
Selling General & Admin Expenses, Total | 16.47M | 28.67M | 34.9M | 48.25M | 60.19M |
R&D Expenses | 27.56M | 34.84M | 47.95M | 76.77M | 95.53M |
Other Operating Expenses, Total | 44.04M | 63.51M | 82.85M | 125M | 156M |
Operating Income | 2.07M | -25.23M | -17.08M | -18.83M | -36.29M |
Other Non Operating Income (Expenses) | 24K | -62K | -245K | 3.32M | 14.31M |
EBT, Excl. Unusual Items | 2.1M | -25.3M | -17.33M | -15.51M | -21.98M |
Asset Writedown | - | - | -4.89M | -2.41M | -765K |
EBT, Incl. Unusual Items | 2.1M | -25.3M | -22.21M | -17.91M | -22.74M |
Income Tax Expense | 766K | 2.22M | -37K | -1.37M | 5.62M |
Earnings From Continuing Operations | 1.33M | -27.51M | -22.18M | -16.55M | -28.37M |
Net Income to Company | 1.33M | -27.51M | -22.18M | -16.55M | -28.37M |
Net Income - (IS) | 1.33M | -27.51M | -22.18M | -16.55M | -28.37M |
Preferred Dividend and Other Adjustments | 1.33M | - | - | - | - |
Net Income to Common Incl Extra Items | 0 | -27.51M | -22.18M | -16.55M | -28.37M |
Net Income to Common Excl. Extra Items | 0 | -27.51M | -22.18M | -16.55M | -28.37M |
Per Share Items | |||||
Net EPS - Basic | - | -0.4 | -0.25 | -0.11 | -0.18 |
Basic EPS - Continuing Operations | - | -0.4 | -0.25 | -0.11 | -0.18 |
Basic Weighted Average Shares Outstanding | 71.73M | 69.1M | 88.4M | 147M | 155M |
Net EPS - Diluted | - | -0.4 | -0.25 | -0.11 | -0.18 |
Diluted EPS - Continuing Operations | - | -0.4 | -0.25 | -0.11 | -0.18 |
Diluted Weighted Average Shares Outstanding | 71.73M | 69.1M | 88.4M | 147M | 155M |
Normalized Basic EPS | 0.02 | -0.23 | -0.12 | -0.07 | -0.09 |
Normalized Diluted EPS | 0.02 | -0.23 | -0.12 | -0.07 | -0.09 |
Supplemental Items | |||||
EBITDA | 3.88M | -23.02M | -12.29M | -9.31M | -22.52M |
EBITA | 2.07M | -25.23M | -17.08M | -18.83M | -36.29M |
EBIT | 2.07M | -25.23M | -17.08M | -18.83M | -36.29M |
EBITDAR | - | - | -9.27M | -5.67M | -18.67M |
Total Revenues (As Reported) | 53.84M | 58.7M | 106M | 184M | 193M |
Effective Tax Rate - (Ratio) | 36.56 | -8.76 | 0.17 | 7.63 | -24.73 |
Current Domestic Taxes | 103K | 302K | 199K | -22K | - |
Current Foreign Taxes | 947K | 544K | 1.29M | 762K | 1.49M |
Total Current Taxes | 1.05M | 846K | 1.49M | 740K | 1.49M |
Deferred Domestic Taxes | -376K | 1.22M | -1.3M | -2.22M | - |
Deferred Foreign Taxes | 92K | 144K | -223K | 116K | 4.14M |
Total Deferred Taxes | -284K | 1.37M | -1.53M | -2.11M | 4.14M |
Normalized Net Income | 1.31M | -15.81M | -10.83M | -9.69M | -13.74M |
Supplemental Operating Expense Items | |||||
Selling and Marketing Expenses | 9.63M | 17.52M | - | - | - |
General and Administrative Expenses | 6.84M | 11.15M | - | - | - |
Research And Development Expense From Footnotes | 27.56M | 34.84M | 47.95M | 76.77M | 95.53M |
Net Rental Expense, Total | - | - | 3.02M | 3.64M | 3.86M |
Stock-Based Comp., COGS (Total) | 33K | 183K | 220K | 634K | 1.13M |
Stock-Based Comp., R&D Exp. (Total) | 584K | 7.74M | 5.02M | 13.33M | 21.36M |
Stock-Based Comp., S&M Exp. (Total) | 480K | 1.97M | - | - | - |
Stock-Based Comp., G&A Exp. (Total) | 150K | 4.02M | - | - | - |
Stock-Based Comp., SG&A Exp. (Total) | - | - | 3.95M | 9.56M | 16.53M |
Total Stock-Based Compensation | 1.25M | 13.91M | 9.19M | 23.52M | 39.02M |